Repare Therapeutics Inc.
RPTX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $3,258 | -$16,744 | -$30,043 | -$28,671 |
| Dep. & Amort. | $72 | $1,036 | $1,186 | $454 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $2,072 | $3,975 | $4,928 |
| Change in WC | $1,111 | -$445 | -$4,275 | -$3,768 |
| Other Non-Cash | -$1,790 | -$2,261 | $24 | -$267 |
| Operating Cash Flow | $2,651 | -$16,342 | -$29,133 | -$27,324 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $1,000 | $0 | $0 |
| Inv. Purchases | -$7,613 | -$38,583 | -$7,873 | -$19,222 |
| Inv. Sales/Matur. | $10,150 | $36,997 | $36,665 | $50,808 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $2,537 | -$586 | $28,792 | $31,586 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $30 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $79 | $1 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $0 |
| Financing Cash Flow | $30 | $0 | $79 | $1 |
| Forex Effect | -$49 | $129 | $0 | -$87 |
| Net Chg. in Cash | $5,169 | -$16,799 | -$262 | $4,176 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $67,656 | $84,455 | $84,717 | $80,541 |
| End Cash | $72,825 | $67,656 | $84,455 | $84,717 |
| Free Cash Flow | $2,651 | -$16,342 | -$29,133 | -$27,324 |